Chronic granulomatous disease - Haematopoietic stem cell transplantation versus conventional treatment

Acta Paediatrica, International Journal of Paediatrics

Volumn 102, Issue 11, 2013, Pages 1087-1094

  Åhlin, Anders ^a   Fugeläng, Jakob ^a   De Boer, Martin ^b   Ringden, Olle ^c   Fasth, Anders ^d   Winiarski, Jacek ^c  

^a SACHS CHILDREN S HOSPITAL   (Sweden)

^b SANQUIN RESEARCH   (Netherlands)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Chronic granulomatous disease; Conventional treatment; Haematopoietic stem cell transplantation; Morbidity; Mortality; Prognosis

Indexed keywords

ADENOVIRUS INFECTION; ADOLESCENT; ADULT; ARTICLE; ATYPICAL MYCOBACTERIOSIS; CHILD; CHRONIC GRANULOMATOUS DISEASE; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; FEMALE; GRAFT REJECTION; HEART ATRIUM THROMBOSIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGIC CYSTITIS; HUMAN; INFANT; INTERMETHOD COMPARISON; LUNG INFECTION; MALE; MORTALITY; MUCOSA INFLAMMATION; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEPTICEMIA; SURVIVAL TIME; SWEDEN; TREATMENT OUTCOME; VERRUCA VULGARIS; VIRUS ACTIVATION;

CHRONIC GRANULOMATOUS DISEASE; CONVENTIONAL TREATMENT; HAEMATOPOIETIC STEM CELL TRANSPLANTATION; MORBIDITY; MORTALITY; PROGNOSIS;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GRANULOMATOUS DISEASE, CHRONIC; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES; SWEDEN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84885370012     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/apa.12384     Document Type: Article

References (29)

1. Segal BH, Veys P, Malech H, Cowan MJ,. Chronic granulomatous disease: lessons from a rare disorder. Biol Blood Marrow Transplant 2011; 17 Suppl 1: S123-31.
2. Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000; 79: 155-69.
3. Mouy R, Veber F, Blanche S, Donadieu J, Brauner R, Levron JC, et al. Long term itraconazole prophylaxis against Aspergillus infection in thirty-two patients with chronic granulomatous disease. J Pediatr 1994; 125: 998-1003.
4. Van den Berg JM, van Koppen E, Ahlin A, Belohradsky BH, Bernatowska E, Corbeel L, et al. Chronic granulomatous disease: the European experience. PLoS ONE 2009; 4: e5234.
5. Rieber N, Hector A, Kuijpers T, Roos D, Hartl D,. Current concepts of hyperinflammation in chronic granulomatous disease. Clin Dev Immunol 2012; 2012: 252460.
6. Kang EM, Marciano BE, DeRavin S, Zarember KA, Holland SM, Malech HL,. Chronic granulomatous disease: overview and hematopoietic stem cell transplantation. J Allergy Clin Immunol 2011; 127: 1319-26.
7. Åhlin A, De Boer M, Roos D, Leusen J, Smith CI, Sundin U, et al. Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden. Acta Paediatr 1995; 84: 1386-94.
8. Seger RA,. Advances in the diagnosis and treatment of chronic granulomatous disease. Curr Opin Hematol 2011; 18: 36-41.
9. Roifman CM, Fischer A, Notarangelo LD, de la Morena MT, Seger RA,. Indications for hemopoietic stem cell transplantation. Immunol Allergy Clin North Am 2010; 30: 261-2.
10. Satwani P, Cooper N, Rao K, Veys P, Amrolia P,. Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases. Bone Marrow Transplant 2008; 41: 173-82.
11. Goudemand J, Anssens R, Delmas-Marsalet Y, Farriaux JP, Fontaine G,. Attempt to treat a case of chronic familial granulomatous disease by allogenic bone marrow transplantation. Arch Fr Pediatr 1976; 33: 121-9.
12. Rappeport JM, Newburger PE, Goldblum RM, Golman AS, Nathan DG, Parkman R,. Allogeneic bone marrow transplantation for chronic granulomatous disease. J Pediatr 1982; 101: 952-5.
13. Seger RA, Gungor T, Belohradsky BH, Blanche S, Bordigoni P, Di Bartolomeo P, et al. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000. Blood 2002; 100: 4344-50.
14. Goździk J, Pituch-Noworolska A, Skoczeń S, Czogała W, Wȩdrychowicz A, Baran J, et al. Allogeneic haematopoietic stem cell transplantation as therapy for chronic granulomatous disease - single centre experience. J Clin Immunol 2008; 31: 332-7.
15. Soncini E, Slatter MA, Jones LB, Hughes S, Hodges S, Flood TJ, et al. Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth. Br J Haematol 2009; 145: 73-83.
16. Kang EM, Kelly C, Hilligoss D, Marquesen M, DeCastro R, Wilder J, et al. A novel non-myeloablative regimen for related and unrelated allogeneic transplantation of high risk patients with chronic granulomatous disease (CGD). Biol Blood Marrow Transplant 2011; 17: 1-5.
17. Kang EM, Malech HL,. Gene therapy for chronic granulomatous disease. Methods Enzymol 2012; 507: 125-54.
18. Schaffer M, Aldener-Cannavá A, Remberger M, Ringdén O, Olerup O,. Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantation. Tissue Antigens 2003; 62: 243-50.
19. Hassan M, Ljungman P, Bolme P, Ringdén O, Syrůcková Z, Békàssy A, et al. Busulfan bioavailability. Blood 1994; 84: 2144-50.
20. Remberger M, Sundberg B,. Cytokine production during myeloablative and reduced intensity therapy before allogeneic stem cell transplantation. Haematologica 2004; 89: 710-6.
21. Ringdén O, Remberger M, Svahn BM, Barkholt L, Mattsson J, Aschan J, et al. Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single center. Transplantation 2006; 81: 718-25.
22. Bolanowski A, Mannon RB, Holland SM, Malech HL, Aschan J, Palmblad J, et al. Successful renal transplantation in patients with chronic granulomatous disease. Am J Transplant 2006; 6: 636-9.
23. Blumental S, Mouy R, Mahlaoui N, Bougnoux ME, Debré M, Beauté J, et al. Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey. Clin Infect Dis 2011; 53: e159-69.
24. Cole T, McKendrick F, Titman P, Cant AJ, Pearce MS, Cale CM, et al. Health related quality of life and emotional health in children with chronic granulomatous disease: a comparison of those managed conservatively with those that have undergone haematopoietic stem cell transplant. J Clin Immunol 2013; 33: 8-13.
25. Remberger M, Mattsson J, Olsson R, Ringdén O,. Second allogeneic hematopoietic stem cell transplantation: a treatment for graft failure. Clin Transplant 2011; 25: E68-76.
26. Schuetz C, Hoenig M, Gatz S, Speth F, Benninghoff U, Schulz A, et al. Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease. Immunol Res 2009; 44: 35-41.
27. Horwitz ME, Barrett AJ, Brown MR, Carter CS, Childs R, Gallin JI, et al. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. N Engl J Med 2001; 344: 881-8.
28. Tewari P, Martin PL, Mendizabal A, Parikh SH, Page KM, Driscoll TA, et al. Myeloablative transplantation using either cord blood or bone marrow leads to immune recovery, high long-term donor chimerism and excellent survival in chronic granulomatous disease. Biol Blood Marrow Transplant 2012; 18: 1368-77.
29. Martinez CA, Shah S, Shearer WT, Rosenblatt HM, Paul ME, Chinen J, et al. Excellent survival after sibling or unrelated donor stem cell transplantation for chronic granulomatous disease. J Allergy Clin Immunol 2012; 129: 176-83.